INAB compared with BSAC: revenue, margins and what each company keeps, and the suppliers and customers both name

INABIN8BIO, Inc.

Mkt capRevenueRevenue

BSACBanco Santander Chile

Mkt capRevenueRevenue

Compare

INABIN8BIO, Inc.

BSACBanco Santander Chile

Price

Mkt cap

Revenue

Revenue flow

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

INAB: latest quarter not drawable. BSAC: latest quarter not drawable.Method ›

direct ties · both sidesSources ›

direct ties · both sides

No disclosed counterparties: INAB, BSAC.

Role chip = supplier or customerSource: SEC EDGAR

rebased to 0%

INAB, solidBSAC, dashed

INABIN8BIO, Inc.

0.94▼−4.09%· post 0.94

Mkt cap$8.9M

BSACBanco Santander Chile

30.51▼−3.12%· post 30.50

ClosedOct 30 '26

Mkt cap$5.8T

Compare

ClosedOct 30 '26

INABIN8BIO, Inc.

BSACBanco Santander Chile

0.94▼−4.09%post 0.94

Price

30.51▼−3.12%post 30.50

$8.9M

Mkt cap

$5.8T

INAB0.94▼−4.09%vsBSAC30.51▼−3.12%ClosedOct 30 '26